IONS
Ionis Pharmaceuticals, Inc. Earnings
$35.63
Earnings Summary
Revenue | $134Mn |
Net Profits | $-140.48Mn |
Net Profit Margins | -104.84% |
Ionis Pharmaceuticals, Inc.’s revenue fell -6.94% since last year same period to $134Mn in the Q3 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -40.51% fall in its revenue since last 3-months.
Ionis Pharmaceuticals, Inc.’s net profit jumped 4.44% since last year same period to $-140.48Mn in the Q3 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -112% fall in its net profits since last 3-months.
Ionis Pharmaceuticals, Inc.’s net profit margin fell -2.7% since last year same period to -104.84% in the Q3 2024. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated -256.36% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Ionis Pharmaceuticals, Inc. post its latest quarter earningsEPS Estimate Current Year | -1.01 |
Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.01.
Key Ratios
Key ratios of the Ionis Pharmaceuticals, Inc. post its Q3 2024 earningsEarning Per Share (EPS) | -0.95 |
Ionis Pharmaceuticals, Inc.’s earning per share (EPS) jumped 7.77% since last year same period to -0.95 in the Q3 2024. This indicates that the Ionis Pharmaceuticals, Inc. has generated 7.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-06 | -1.16 | -0.95 | 18.1% |
2024-08-01 | -0.92 | -0.45 | 51.09% |
2024-03-31 | -1.05 | -0.98 | 6.67% |
₹0 US Stocks a/c Opening Fee